Recent findings showed that TAZ (Transcriptional co-activator with PDZ-binding motif), another downstream effector of the Hippo signaling pathway, but not YAP, is predominantly expressed in HCC. The gene discussed is YAP1; the disease is hepatocellular carcinoma.